Unmasking Cardiac Sarcoidosis: Integrating Multimodal Imaging with Histochemical and Ultrastructural Analysis
International Journal of Molecular Sciences · 25.03.2026 · 27 (7) · 2969
DOI: 10.3390/ijms27072969 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.03.2026. Verfasst von Jakub Kancerek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Cell Pathology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-808 Zabrze, Poland. Hauptthemen laut MEDLINE: Sarcoidosis, Multimodal Imaging, Cardiomyopathies. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiac sarcoidosis (CS) is a critical and frequently underdiagnosed phenotype of sarcoidosis, characterized by non-caseating granulomatous infiltration of the myocardium. This review synthesizes current knowledge regarding the pathogenesis, diagnosis, and management of CS. The disease manifests with a heterogeneous clinical spectrum ranging from asymptomatic conduction abnormalities to life-threatening ventricular arrhythmias and heart failure. Diagnosis remains challenging due to the patchy distribution of granulomas, which limits the sensitivity of endomyocardial biopsy. Consequently, a multimodal diagnostic approach is essential, integrating advanced imaging modalities such as cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE) and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). These tools not only facilitate detection but also enable the differentiation of active inflammation from chronic fibrosis. Histopathological assessment, supported by specific immunophenotyping and electron microscopy, remains the gold standard for confirming diagnosis and excluding mimics like giant cell myocarditis or infectious granulomatous diseases. Management requires a multidisciplinary strategy combining immunosuppressive therapy, primarily corticosteroids and steroid-sparing agents, with guideline-directed cardiac care, including implantable cardioverter-defibrillators for arrhythmia risk stratification. Emerging biomarkers and artificial intelligence-driven imaging analysis promise to further refine risk stratification and therapeutic monitoring, advancing precision medicine in this complex disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Histology and Cell Pathology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-808 Zabrze, Poland.
ORCID-Profile: Jakub Kancerek, Damian Świerczek, Wiktoria Baron, Piotr Lewandowski, Romuald Wojnicz
Zitieren
APA
Kancerek, J., Świerczek, D., Baron, W., Rojek, M., Lewandowski, P., & Wojnicz, R. (2026). Unmasking Cardiac Sarcoidosis: Integrating Multimodal Imaging with Histochemical and Ultrastructural Analysis. International Journal of Molecular Sciences, 27(7), 2969. https://doi.org/10.3390/ijms27072969
Vancouver
Kancerek J, Świerczek D, Baron W, Rojek M, Lewandowski P, Wojnicz R. Unmasking Cardiac Sarcoidosis: Integrating Multimodal Imaging with Histochemical and Ultrastructural Analysis. International Journal of Molecular Sciences. 2026;27(7):2969. doi:10.3390/ijms27072969
BibTeX
@article{Kancerek2026,
author = {Kancerek, Jakub and Świerczek, Damian and Baron, Wiktoria and Rojek, Marcin and Lewandowski, Piotr and Wojnicz, Romuald},
title = {Unmasking Cardiac Sarcoidosis: Integrating Multimodal Imaging with Histochemical and Ultrastructural Analysis},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {2969},
doi = {10.3390/ijms27072969}
}
EUVIMED